Details of the Drug

General Information of Drug (ID: DMIYBGZ)

• Drug Name: NPS-31807
• Synonyms: PP-05; TNF alpha modulator (inflammation), Piramal Life Sciences; TNF alpha modulator (inflammation), NPIL Research & Development

Indication

Disease Entry	ICD 11	Status	REF
Psoriasis vulgaris	EA90	Phase 4	[1]

• Cross-matching ID: TTD ID: D0S0ST

References

• [1] ClinicalTrials.gov (NCT01373567) A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis. U.S. National Institutes of Health.